Related Experiment Video
Updated: Jun 20, 2026
Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
Published on: February 24, 2021
Platelet-rich plasma versus granulocyte colony-stimulating factor in addressing recurrent implantation failure: A
Hatav Ghasemi Tehrani1, Elnaz Mostajeran1, Reihaneh Dehghani-Mohammadabadi1
1Department of Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Background:
The aim of the study is to evaluate the effect of platelet-rich plasma (PRP) versus granulocyte colony-stimulating factor in addressing recurrent implantation failure.
Materials And Methods:
Fifty patients were randomly assigned to two treatment groups: PRP and granulocyte colony-stimulating factor (GCSF). All patients were followed up to 12 weeks after implantation. The rate of positive pregnancy tests (chemical pregnancy), implantation rate (clinical pregnancy), and pregnancy reaching 12 weeks old (ongoing pregnancy) in these two groups was compared.
Results:
Biochemical pregnancy, gestational sac formation, fetal heart formation, and 12-week pregnancy occurred in 6 (24%), 6 (24%), 6 (24%), and 5 women (20%) in the PRP group and occurred in 7 women (28%), 5 women (20%), 5 women (20%), and 5 women (20%) in the GCSF group. There was no statistically significant difference regarding biochemical pregnancy, gestational sac formation, fertile heart formation, and 12-week-old pregnancy between study groups (P = 0.747, 0.737, 0.737, and 1, respectively).
Conclusion:
Our study showed no difference in the efficacy of plasma-rich platelets and GCSFs in treating recurrent implantation failure.
